Article

Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial

2023-02-08

Abstract excerpt

<title>Abstract</title> <p>Metastatic and high-risk localized prostate cancer respond to hormone therapy but outcomes vary. Following a pre-specified statistical plan, we used Cox models adjusted for clinical variables to test associations with survival of multi-gene expression-based classifiers from 781 patients randomized to androgen deprivation with or without abiraterone in the STAMPEDE trial. Decipher score...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a3a8814d-fd43-581d-9720-1ccf7d033c8a
DOI: 10.21203/rs.3.rs-2488586/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trialDOI 10.21203/rs.3.rs-2488586/v1Read

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancersSemantic proximity Read

Genomic Classifiers and Prognosis of Localized Prostate Cancer: A Systematic ReviewSemantic proximity Read

Integrated single-cell and spatial transcriptomic analyses unravel the heterogeneity of the prostate tumor microenvironmentSemantic proximity Read

Liquid-biopsy transcriptomic profiling uncovers molecular mediators of resistance to androgen receptor signaling inhibition in lethal prostate cancerSemantic proximity Read

Determinant of aggressive phenotype in metastatic hormone sensitive prostate cancer depends on an intrinsic, highly aggressive cell cluster: Integrated single- cell and whole transcriptomic analysesSemantic proximity Read

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancerSemantic proximity Read

Transcriptional mediators of treatment resistance in lethal prostate cancerSemantic proximity Read

Insights into Immune Microenvironment and Therapeutic Targeting in Androgen-Associated Prostate Cancer SubtypesSemantic proximity Read

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerSemantic proximity Read

Genomic correlates of clinical outcome in advanced prostate cancerSemantic proximity Read

The transcriptional landscape of metastatic hormone-naïve prostate cancerSemantic proximity Read

Integrated single-cell and spatial transcriptomic analyses unravel the heterogeneity of the prostate tumor microenvironmentSemantic proximity Read